GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Xlife Sciences AG (GREY:XLSCF) » Definitions » Operating Margin %

Xlife Sciences AG (Xlife Sciences AG) Operating Margin % : -1,460.27% (As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Xlife Sciences AG Operating Margin %?

Operating Margin % is calculated as Operating Income divided by its Revenue. Xlife Sciences AG's Operating Income for the six months ended in Dec. 2023 was $-10.81 Mil. Xlife Sciences AG's Revenue for the six months ended in Dec. 2023 was $0.74 Mil. Therefore, Xlife Sciences AG's Operating Margin % for the quarter that ended in Dec. 2023 was -1,460.27%.

The historical rank and industry rank for Xlife Sciences AG's Operating Margin % or its related term are showing as below:

XLSCF' s Operating Margin % Range Over the Past 10 Years
Min: -2055.47   Med: -779.09   Max: -149.13
Current: -2055.47


XLSCF's Operating Margin % is ranked worse than
80.39% of 1030 companies
in the Biotechnology industry
Industry Median: -173.23 vs XLSCF: -2055.47

Xlife Sciences AG's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

Xlife Sciences AG's Operating Income for the six months ended in Dec. 2023 was $-10.81 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Dec. 2023 was $-22.98 Mil.

Warning Sign:

Xlife Sciences AG has never been profitable in the past 3 years. It lost money every year.


Xlife Sciences AG Operating Margin % Historical Data

The historical data trend for Xlife Sciences AG's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xlife Sciences AG Operating Margin % Chart

Xlife Sciences AG Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Operating Margin %
Get a 7-Day Free Trial -149.24 -778.97 -649.37 -2,042.07 -2,056.30

Xlife Sciences AG Semi-Annual Data
Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only -533.77 -2,812.27 -1,605.97 -3,154.40 -1,460.27

Competitive Comparison of Xlife Sciences AG's Operating Margin %

For the Biotechnology subindustry, Xlife Sciences AG's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Xlife Sciences AG's Operating Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Xlife Sciences AG's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Xlife Sciences AG's Operating Margin % falls into.



Xlife Sciences AG Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Xlife Sciences AG's Operating Margin % for the fiscal year that ended in Dec. 2023 is calculated as

Operating Margin %=Operating Income (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=-23.483 / 1.142
=-2,056.30 %

Xlife Sciences AG's Operating Margin % for the quarter that ended in Dec. 2023 is calculated as

Operating Margin %=Operating Income (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=-10.806 / 0.74
=-1,460.27 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Xlife Sciences AG  (GREY:XLSCF) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Xlife Sciences AG Operating Margin % Related Terms

Thank you for viewing the detailed overview of Xlife Sciences AG's Operating Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Xlife Sciences AG (Xlife Sciences AG) Business Description

Traded in Other Exchanges
Address
Talacker 35, Zürich, CHE, 8001
Xlife Sciences AG is a Swiss company with a focus on performance technologies in life sciences. The company allows its investors a very early and direct Entry into the further development of innovative and future-oriented technologies.

Xlife Sciences AG (Xlife Sciences AG) Headlines